PRIVACY ALERT: AWKO Law LLP Investigates Quest Diagnostics for Data Breach of Patient RecordsBusiness Wire · 1 day ago
Lab testing giant Quest Diagnostics confirms patients' personal and health data was compromised during breachTechCrunch · 1 day ago
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-TermZacks Investment Research · 1 day ago
DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-MarketZacks Investment Research · 2 days ago
What Quest Diagnostics (DGX) Said on Its Q3 Earnings CallMarketBeat · 2 days ago
Quest Diagnostics: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 2 days agoQuest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients.
| Date | Est. | Actual | |
|---|---|---|---|
| Oct 22, 2026 | $2.87 | $3.00 | Beat |
| Jul 23, 2026 | $2.82 | $3.12 | Beat |
| Apr 21, 2026 | $2.37 | $2.50 | Beat |
| Feb 10, 2026 | $2.36 | $2.42 | Beat |
| Oct 21, 2025 | $2.50 | $2.60 | Beat |
| Jul 22, 2025 | $2.57 | $2.62 | Beat |